Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -49,620 | -30,536 | -11,618 | -106,519 | -92,529 |
| Depreciation Amortization | 8,661 | 5,887 | 2,946 | 11,487 | 8,588 |
| Accounts receivable | -23,886 | -14,518 | -14,640 | -10,827 | -3,475 |
| Other Working Capital | -39,107 | -5,012 | -17,511 | 88,386 | 39,155 |
| Other Operating Activity | 50,706 | 32,479 | 22,926 | 44,845 | 24,816 |
| Operating Cash Flow | $-53,246 | $-11,700 | $-17,897 | $27,372 | $-23,445 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -34,689 | -106,794 | 40,991 | -67,277 | -114,470 |
| PPE Investments | -19,117 | -9,789 | -3,047 | -18,446 | -7,716 |
| Other Investing Activity | -50 | -50 | 0 | 0 | 0 |
| Investing Cash Flow | $-53,856 | $-116,633 | $37,944 | $-85,723 | $-122,186 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -83,304 | -82,148 | N/A | N/A | N/A |
| Common Stock Issued | 6,165 | 3,685 | 1,903 | 319,400 | 5,171 |
| Financing Cash Flow | $-77,139 | $-78,463 | $1,903 | $319,400 | $5,171 |
| Beginning Cash Position | 498,925 | 498,925 | 498,925 | 237,876 | 237,876 |
| End Cash Position | 314,684 | 292,129 | 520,875 | 498,925 | 97,416 |
| Net Cash Flow | $-184,241 | $-206,796 | $21,950 | $261,049 | $-140,460 |
| Free Cash Flow | |||||
| Operating Cash Flow | -53,246 | -11,700 | -17,897 | 27,372 | -23,445 |
| Capital Expenditure | -19,117 | -9,789 | -3,047 | -18,446 | -7,716 |
| Free Cash Flow | -72,363 | -21,489 | -20,944 | 8,926 | -31,161 |